Skip to content
Agriculture Farming Rural, Medical Health Aged Care

CPMC Warns AHPRA’s Plan Won’t Fix Doctor Shortages in Regional Areas and Key Specialties

Council of Presidents of Medical Colleges 3 mins read

Following the release of the Unleashing the Potential of our Health Workforce Report, the Council of Presidents of Medical Colleges (CPMC) has again warned that fast-tracking International Medical Graduate registration alone will not solve Australia's rural healthcare challenges.

Without proper planning, new specialists may concentrate in urban areas while regional communities continue to face specialist shortages.

"We are reviewing the broader health workforce reform agenda outlined in the Scope of Practice Review and will consider the recommendations in the context of all the current health workforce reforms.  We cannot accept an implementation approach for international medical registration that fails to address the fundamental challenge of ensuring all Australians have access to appropriate specialist care," said A/Prof Sanjay Jeganathan, Chair of CPMC.

"Regional Australians deserve the same quality healthcare as city residents, yet the current approach risks widening rather than closing these geographical healthcare gaps."

CPMC reaffirms its commitment to working constructively with AHPRA, the Medical Board of Australia, Minister Butler, and state and territory ministers on international medical registration and broader workforce reforms. We emphasise that any changes to registration pathways must be part of a comprehensive strategy that genuinely addresses workforce distribution and maintains Australia's high standards of specialist care. Practising medical specialists and GPs through the colleges need to be part of the process.

Evidence shows that while SIMG registrations have increased by 27% under current pathways, these specialists need to flow to regional areas where they are most needed.

"While CPMC supports appropriately qualified specialists helping to address workforce challenges, success depends on implementing proper systems to ensure they are directed to communities with the greatest needs, supported by robust quality assurance processes," said A/Prof Jeganathan.

CPMC's concerns about the expedited pathway implementation include:

  1. No clear mechanisms to direct specialists to areas of genuine workforce shortage
  2. Lack of detail about maintaining standards through the qualification equivalency process
  3. Absence of strategies to ensure long-term retention in rural and regional areas
  4. Limited integration with existing specialist training pathways
  5. Insufficient consideration of speciality-specific challenges
  6. Inadequate detail about supervision and quality assurance processes

"Fast-tracking overseas specialists without addressing underlying distribution issues won't solve our core challenges," explained A/Prof Jeganathan. "Rural Australians will still face the same barriers to accessing specialist care, and understaffed specialities may remain under-resourced."

While AHPRA has indicated that the Australian Medical Council will assess qualification equivalency, CPMC maintains that successful implementation requires:

  • Transparent criteria for assessing international qualifications
  • Clear supervision and monitoring frameworks
  • Integration with existing workforce distribution initiatives
  • Speciality-specific approaches that recognise different practice requirements
  • Robust evaluation mechanisms to ensure safety and effectiveness

"The specialist medical colleges have extensive experience in assessing international medical graduates and understanding the unique requirements of specialist practice in Australia, particularly in rural and remote settings," said A/Prof Jeganathan. "This expertise must be properly utilised to ensure these reforms achieve their intended outcomes."

"We remain committed to supporting initiatives that will genuinely improve access to specialist care for all Australians," concluded A/Prof Jeganathan. "However, these initiatives must be properly planned, adequately detailed, and effectively targeted to address real workforce needs."


Key Facts:

CPMC's concerns about the expedited SIMG pathway implementation include:

  1. No clear mechanisms to direct specialists to areas of genuine workforce shortage
  2. Lack of detail about maintaining standards through the qualification equivalency process
  3. Absence of strategies to ensure long-term retention in rural and regional areas
  4. Limited integration with existing specialist training pathways
  5. Insufficient consideration of speciality-specific challenges
  6. Inadequate detail about supervision and quality assurance processes

About us:

The Council of Presidents of Medical Colleges (CPMC) is Australia's peak body representing specialist medical colleges. Find us at: www.cpmc.edu.au or Twitter: @CPMC_Aust


Contact details:

CEO, CPMC

Phone: +61 413 802 600 or 1300 603 157  

Email: [email protected]

More from this category

  • Medical Health Aged Care
  • 29/04/2025
  • 00:10
Olon SpA

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

MILAN, April 28, 2025 (GLOBE NEWSWIRE) -- Olon Group, a leading global pharmaceutical CDMO, announces the appointment of Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP CDMO of Olon Biotech, the division dedicated to CDMO services for biologics. These appointments reinforce Olon's strategy to expand its capabilities in Antibody-Drug Conjugates (ADCs), Highly Potent Active Pharmaceutical Ingredients (HPAPIs), and microbial bioproduction.An Integrated Vision for ADCs, HPAPIs, and Microbial BioproductionWith this new leadership structure, Olon Group is accelerating the development of its fully integrated ADC offering, covering the entire value chain from Cell Line Development (CLD) to…

  • Medical Health Aged Care
  • 28/04/2025
  • 22:41
Mainstay Medical Holdings plc

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Anthem Blue Cross/Blue Shield

DUBLIN--BUSINESS WIRE-- Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield (“Anthem”) has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. The coverage went into effect on April 16, 2025, and expands access to the procedure, when clinically appropriate, to Anthem’s policyholders. “We have been on a 17-year mission to prove the value of ReActiv8 through careful and thorough research,”said Jason Hannon, CEO of Mainstay Medical.“We have…

  • Medical Health Aged Care
  • 28/04/2025
  • 21:26
Eurosets

Life-saving Technologies at EuroELSO 2025: Eurosets Presents Landing Breathe and Xtreme Rescue

MILAN–BUSINESS WIRE– Eurosets, a cutting-edge Italian company specializing in the design of life-saving medical devices, unveils two crucial innovations at the EuroELSO 2025 congress:…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.